Rivastigmine improves dual-task gait velocity in patients with Alzheimer’s disease
Abstract Background Gait impairments are common in patients with Alzheimer’s disease. Cholinesterase inhibitors are used to treat the symptoms of patients with Alzheimer’s disease, but they have not been shown to reduce the severity of Alzheimer’s disease-related gait disorders. Methods This was a p...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2021-02-01
|
| Series: | BMC Neurology |
| Online Access: | https://doi.org/10.1186/s12883-021-02098-8 |